PATIENTS WITH KNEE OSTEOARTHRITIS DEMONSTRATE IMPROVED GAIT PATTERN AND REDUCED PAIN FOLLOWING A NON-INVASIVE BIOMECHANICAL THERAPY: A PROSPECTIVE MULTI-CENTRE STUDY IN AN ASIAN POPULATION

被引：0
|
作者：
Mor, Amit [1 ]
Elbaz, Avi [1 ]
Segal, Ganit [1 ]
Aloni, Yoav [1 ]
Yee, Hong Teo [2 ]
Yee, Sze Teo [3 ]
Das De, Shamal [4 ]
Seng, Jin Yeo [5 ]
机构：
[1] AposTherapy, Res Grp, Herzliyya, Israel
[2] Tan Tock Seng Hosp, Dept Orthopaed Surg, Singapore, Singapore
[3] Changi Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117548, Singapore
[5] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
194
引用
收藏
页码：132 / 132
页数：1
相关论文
共 23 条
  • [21] OUTCOMES IN PATIENTS WITH DIABETES MELLITUS AND SUSPECTED CORONARY ARTERY DISEASE FOLLOWING NON-INVASIVE TESTING: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN)
    Sharma, Abhinav
    Sekaran, Nishant
    Coles, Adrian
    Pagidipati, Neha
    Mark, Daniel
    Lee, Kerry
    Al-Khalidi, Hussein
    Lu, Michael T.
    Hoffmann, Udo
    Douglas, Pamela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 58 - 58
  • [22] Osimertinib with chemotherapy as fi rst-line therapy for patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) non-small cell lung cancer (NSCLC): A prospective, multi-centre, real-world study (FOREFRONT)
    Han, B.
    Wang, Q.
    Zhang, B.
    Lv, D.
    Yao, W.
    Yu, Y.
    Zhuo, M.
    ANNALS OF ONCOLOGY, 2024, 35
  • [23] A prospective, open-label, multi-centre phase II study to investigate the safety and efficacy of a combination therapy with nivolumab, ipilimumab and bevacizumab together with 2 cycles of induction chemotherapy in patients with non-squamosisNSCLC with brain metastases (CA209-7WF/Break B5)
    Heudobler, D.
    Schulz, C.
    Illerhaus, G.
    Janning, M.
    Griesinger, F.
    Lueke, F.
    Herr, W.
    Pukrop, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 208 - 209
123